FDA Biologics (BLA & Biosimilars)Original article
FDA Roundtable: Strengthening the Supply Chain for Blood Manufacturing - 09/29/2026
Whole BloodBlood componentsSource PlasmaNeutral
AI Analysis
Summary
The FDA's Center for Biologics Evaluation and Research is hosting a roundtable discussion on September 29, 2026, to address strengthening the supply chain for whole blood, blood components, and source plasma collection and manufacturing for transfusion purposes.
Importance:2/10
Sentiment:
0.00
FDABlood supply chainRegulatoryCBERManufacturing
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on August 28, 2026 6:53 PM